1057 Vemurafenib acts as an aryl hydrocarbon receptor antagonist

Handle URI:
http://hdl.handle.net/10754/627592
Title:
1057 Vemurafenib acts as an aryl hydrocarbon receptor antagonist
Authors:
Hawerkamp, H.C.; Kislat, A.; Gerber, P.; Pollet, M.; Soshilov, A.A.; Denison, M.S.; Momin, A.A.; Arold, Stefan T. ( 0000-0001-5278-0668 ) ; Datsi, A.; Braun, S.A.; Lacouture, M.E.; Haarmann-Stemmann, T.; Homey, B.; Meller, S.
KAUST Department:
Biological and Environmental Sciences and Engineering (BESE) Division; Bioscience Program; Computational Bioscience Research Center (CBRC); Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division
Citation:
Hawerkamp HC, Kislat A, Gerber P, Pollet M, Soshilov AA, et al. (2018) 1057 Vemurafenib acts as an aryl hydrocarbon receptor antagonist. Journal of Investigative Dermatology 138: S179. Available: http://dx.doi.org/10.1016/j.jid.2018.03.1070.
Publisher:
Elsevier BV
Journal:
Journal of Investigative Dermatology
Conference/Event name:
International Investigative Dermatology (IID) 2018
Issue Date:
19-Apr-2018
DOI:
10.1016/j.jid.2018.03.1070
Type:
Poster
ISSN:
0022-202X
Additional Links:
http://www.sciencedirect.com/science/article/pii/S0022202X1831296X; http://iid2018.org/
Appears in Collections:
Posters; Bioscience Program; Computational Bioscience Research Center (CBRC); Biological and Environmental Sciences and Engineering (BESE) Division; Computer, Electrical and Mathematical Sciences and Engineering (CEMSE) Division

Full metadata record

DC FieldValue Language
dc.contributor.authorHawerkamp, H.C.en
dc.contributor.authorKislat, A.en
dc.contributor.authorGerber, P.en
dc.contributor.authorPollet, M.en
dc.contributor.authorSoshilov, A.A.en
dc.contributor.authorDenison, M.S.en
dc.contributor.authorMomin, A.A.en
dc.contributor.authorArold, Stefan T.en
dc.contributor.authorDatsi, A.en
dc.contributor.authorBraun, S.A.en
dc.contributor.authorLacouture, M.E.en
dc.contributor.authorHaarmann-Stemmann, T.en
dc.contributor.authorHomey, B.en
dc.contributor.authorMeller, S.en
dc.date.accessioned2018-04-24T05:57:45Z-
dc.date.available2018-04-24T05:57:45Z-
dc.date.issued2018-04-19en
dc.identifier.citationHawerkamp HC, Kislat A, Gerber P, Pollet M, Soshilov AA, et al. (2018) 1057 Vemurafenib acts as an aryl hydrocarbon receptor antagonist. Journal of Investigative Dermatology 138: S179. Available: http://dx.doi.org/10.1016/j.jid.2018.03.1070.en
dc.identifier.issn0022-202Xen
dc.identifier.doi10.1016/j.jid.2018.03.1070en
dc.identifier.urihttp://hdl.handle.net/10754/627592-
dc.publisherElsevier BVen
dc.relation.urlhttp://www.sciencedirect.com/science/article/pii/S0022202X1831296Xen
dc.relation.urlhttp://iid2018.org/-
dc.title1057 Vemurafenib acts as an aryl hydrocarbon receptor antagonisten
dc.typePosteren
dc.contributor.departmentBiological and Environmental Sciences and Engineering (BESE) Divisionen
dc.contributor.departmentBioscience Programen
dc.contributor.departmentComputational Bioscience Research Center (CBRC)en
dc.contributor.departmentComputer, Electrical and Mathematical Sciences and Engineering (CEMSE) Divisionen
dc.identifier.journalJournal of Investigative Dermatologyen
dc.conference.dateMay 16-19, 2018-
dc.conference.nameInternational Investigative Dermatology (IID) 2018-
dc.conference.locationOrlando, Florida-
dc.contributor.institutionDermatology Dept, HHU, Düsseldorf, Germanyen
dc.contributor.institutionIUF Düsseldorf, Düsseldorf, Germanyen
dc.contributor.institutionETOX Dept, UC Davis, Davis, CAen
dc.contributor.institutionDepartment of Dermatology, University Hospital Duesseldorf, Düsseldorf, Germanyen
dc.contributor.institutionDermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NYen
dc.contributor.institutionHHU, Düsseldorf, Germanyen
kaust.authorMomin, A.A.en
kaust.authorArold, Stefan T.en
All Items in KAUST are protected by copyright, with all rights reserved, unless otherwise indicated.